{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:34:54Z","timestamp":1792406094900,"version":"4.4.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R59-A5404"],"award-info":[{"award-number":["R59-A5404"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0215398","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T17:37:23Z","timestamp":1555090643000},"page":"e0215398","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["MEK1\/2 inhibitor U0126, but not nimodipine, reduces upregulation of cerebrovascular contractile receptors after subarachnoid haemorrhage in rats"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5754-1068","authenticated-orcid":true,"given":"Simon T.","family":"Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Radziwon-Balicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Warfvinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5182-8957","authenticated-orcid":true,"given":"Kristian A.","family":"Haanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Edvinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMra052732","article-title":"Aneurysmal subarachnoid hemorrhage","volume":"354","author":"JI Suarez","year":"2006","journal-title":"N Engl J Med"},{"issue":"9558","key":"ref2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0140-6736(07)60153-6","article-title":"Subarachnoid haemorrhage","volume":"369","author":"J van Gijn","year":"2007","journal-title":"Lancet"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11883-017-0690-x","article-title":"Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: Beyond Vasospasm and Towards a Multifactorial Pathophysiology","volume":"19","author":"JR Geraghty","year":"2017","journal-title":"Curr Atheroscler Rep"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3390\/ijms17040497","article-title":"Aneurysmal Subarachnoid Hemorrhage and Neuroinflammation: A Comprehensive Review","volume":"17","author":"BP Lucke-Wold","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/0271678X15617172","article-title":"Molecular pathophysiology of cerebral edema","volume":"36","author":"JA Stokum","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref6","first-page":"1","article-title":"Cerebral Vasospasm: A Review","volume":"2015","author":"JM Findlay","journal-title":"Can J Neurol Sci"},{"issue":"3","key":"ref7","first-page":"CD000277","article-title":"Calcium antagonists for aneurysmal subarachnoid haemorrhage","author":"SM Dorhout Mees","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"ref8","article-title":"Management of patients with aneurysmal subarachnoid haemorrhage","author":"GJ Rinkel","year":"2015","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/american Stroke Association","volume":"43","author":"ES Connolly Jr.","year":"2012","journal-title":"Stroke"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000346087","article-title":"European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage","volume":"35","author":"T Steiner","year":"2013","journal-title":"Cerebrovasc Dis"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S1474-4422(14)70084-5","article-title":"Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial","volume":"13","author":"PJ Kirkpatrick","year":"2014","journal-title":"Lancet Neurol"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12975-013-0316-8","article-title":"Current management of delayed cerebral ischemia: update from results of recent clinical trials","volume":"5","author":"S Brathwaite","year":"2014","journal-title":"Transl Stroke Res"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/jcbfm.2015.89","article-title":"Effect of endothelin receptor antagonists on clinically relevant outcomes after experimental subarachnoid hemorrhage: a systematic review and meta-analysis","volume":"35","author":"KG Laban","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/jcbfm.2011.70","article-title":"Vascular plasticity in cerebrovascular disorders","volume":"31","author":"LI Edvinsson","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12975-014-0331-4","article-title":"Plasticity of cerebrovascular smooth muscle cells after subarachnoid hemorrhage","volume":"5","author":"L Edvinsson","year":"2014","journal-title":"Transl Stroke Res"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/jcbfm.2014.205","article-title":"MEK1\/2 inhibitor U0126 but not endothelin receptor antagonist clazosentan reduces upregulation of cerebrovascular contractile receptors and delayed cerebral ischemia, and improves outcome after subarachnoid hemorrhage in rats","volume":"35","author":"GK Povlsen","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/jcbfm.2010.62","article-title":"Blockade of the MEK\/ERK pathway with a raf inhibitor prevents activation of pro-inflammatory mediators in cerebral arteries and reduction in cerebral blood flow after subarachnoid hemorrhage in a rat model","volume":"31","author":"A Maddahi","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/1742-2094-9-274","article-title":"Regulation of enhanced cerebrovascular expression of proinflammatory mediators in experimental subarachnoid hemorrhage via the mitogen-activated protein kinase kinase\/extracellular signal-regulated kinase pathway","volume":"9","author":"A Maddahi","year":"2012","journal-title":"J Neuroinflammation"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0271678X16655551","article-title":"Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers","volume":"36","author":"RG Rempe","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cellsig.2018.08.019","article-title":"Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity","volume":"52","author":"A Frismantiene","year":"2018","journal-title":"Cell Signal"},{"issue":"18","key":"ref21","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1097\/00001756-200212200-00034","article-title":"A new experimental model in rats for study of the pathophysiology of subarachnoid hemorrhage","volume":"13","author":"GF Prunell","year":"2002","journal-title":"Neuroreport"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjp.0705803","article-title":"Importance of ERK1\/2 in upregulation of endothelin type B receptors in cerebral arteries","volume":"142","author":"M Henriksson","year":"2004","journal-title":"Br J Pharmacol"},{"issue":"1\u20133","key":"ref23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejphar.2010.06.053","article-title":"Comparison of MEK\/ERK pathway inhibitors on the upregulation of vascular G-protein coupled receptors in rat cerebral arteries","volume":"644","author":"H Sandhu","year":"2010","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3171\/2010.6.JNS1018","article-title":"Improvement in neurological outcome and abolition of cerebrovascular endothelin B and 5-hydroxytryptamine 1B receptor upregulation through mitogen-activated protein kinase kinase 1\/2 inhibition after subarachnoid hemorrhage in rats","volume":"114","author":"CC Larsen","year":"2011","journal-title":"J Neurosurg"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1227\/01.NEU.0000340685.06407.FD","article-title":"Dose-related efficacy of a continuous intracisternal nimodipine treatment on cerebral vasospasm in the rat double subarachnoid hemorrhage model","volume":"64","author":"D Hanggi","year":"2009","journal-title":"Neurosurgery"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-8118-8-7","article-title":"Drug transport in brain via the cerebrospinal fluid","volume":"8","author":"WM Pardridge","year":"2011","journal-title":"Fluids Barriers CNS"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.clineuro.2008.05.001","article-title":"Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy","volume":"110","author":"D Hanggi","year":"2008","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s13311-016-0424-8","article-title":"A Site-Specific, Sustained-Release Drug Delivery System for Aneurysmal Subarachnoid Hemorrhage","volume":"13","author":"D Hanggi","year":"2016","journal-title":"Neurotherapeutics"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0300-9572(93)90006-C","article-title":"Failure of nimodipine to prevent brain damage in a global brain ischemia model in the rat","volume":"25","author":"PA Calle","year":"1993","journal-title":"Resuscitation"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneumeth.2004.04.030","article-title":"Subcutaneous administration of nimodipine improves bioavailability in rabbits","volume":"139","author":"AM Laslo","year":"2004","journal-title":"J Neurosci Methods"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.brainres.2006.01.045","article-title":"Nimodipine treatment to assess a modified mouse model of intracerebral hemorrhage","volume":"1078","author":"B Ma","year":"2006","journal-title":"Brain Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jchromb.2016.06.012","article-title":"Simple and validated UHPLC-MS\/MS analysis of nimodipine in plasma and cerebrospinal fluid of patients with subarachnoid haemorrhage","volume":"1028","author":"S Mohamed","year":"2016","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12028-018-0575-z","article-title":"Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]","volume":"30","author":"D Hanggi","year":"2019","journal-title":"Neurocrit Care"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/01.STR.26.4.644","article-title":"Environment influences functional outcome of cerebral infarction in rats","volume":"26","author":"AL Ohlsson","year":"1995","journal-title":"Stroke"},{"issue":"10","key":"ref35","doi-asserted-by":"crossref","first-page":"e0186504","DOI":"10.1371\/journal.pone.0186504","article-title":"A novel multicolor flow-cytometry application for quantitative detection of receptors on vascular smooth muscle cells","volume":"12","author":"A Radziwon-Balicka","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/apha.12519","article-title":"Cerebrovascular endothelin-1 hyper-reactivity is associated with transient receptor potential canonical channels 1 and 6 activation and delayed cerebral hypoperfusion after forebrain ischaemia in rats","volume":"214","author":"SE Johansson","year":"2015","journal-title":"Acta Physiol (Oxf)"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"H3750","DOI":"10.1152\/ajpheart.00857.2007","article-title":"Cerebrovascular ETB, 5-HT1B, and AT1 receptor upregulation correlates with reduction in regional CBF after subarachnoid hemorrhage","volume":"293","author":"S Ansar","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"13","key":"ref38","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"H Gelderblom","year":"2001","journal-title":"Eur J Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejps.2015.10.015","article-title":"Use of solubilizers in preclinical formulations: Effect of Cremophor EL on the pharmacokinetic properties on early discovery compounds","volume":"87","author":"B Liu","year":"2016","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0006-291X(89)92260-2","article-title":"Cremophor EL, a widely used parenteral vehicle, is a potent inhibitor of protein kinase C","volume":"159","author":"FK Zhao","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2202-8-7","article-title":"Protein kinase C inhibition attenuates vascular ETB receptor upregulation and decreases brain damage after cerebral ischemia in rat","volume":"8","author":"M Henriksson","year":"2007","journal-title":"BMC Neurosci"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/STROKEAHA.107.487827","article-title":"Subtype activation and interaction of protein kinase C and mitogen-activated protein kinase controlling receptor expression in cerebral arteries and microvessels after subarachnoid hemorrhage","volume":"39","author":"S Ansar","year":"2008","journal-title":"Stroke"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3171\/2007.3.16738","article-title":"Equal contribution of increased intracranial pressure and subarachnoid blood to cerebral blood flow reduction and receptor upregulation after subarachnoid hemorrhage. Laboratory investigation","volume":"111","author":"S Ansar","year":"2009","journal-title":"J Neurosurg"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1093\/brain\/awx214","article-title":"Subarachnoid blood acutely induces spreading depolarizations and early cortical infarction","volume":"140","author":"JA Hartings","year":"2017","journal-title":"Brain"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2017.07.013","article-title":"Endothelin receptor mediated Ca(2+) signaling in coronary arteries after experimentally induced ischemia\/reperfusion injury in rat","volume":"111","author":"SB Kristiansen","year":"2017","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1161\/STROKEAHA.117.016603","article-title":"Response by Hanggi and Macdonald to Letter Regarding Article, "Randomized, Open-Label, Phase 1\/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])"","volume":"48","author":"D Hanggi","year":"2017","journal-title":"Stroke"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/STROKEAHA.116.014250","article-title":"Randomized, Open-Label, Phase 1\/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])","volume":"48","author":"D Hanggi","year":"2017","journal-title":"Stroke"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2202-10-56","article-title":"Enhanced cerebrovascular expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 via the MEK\/ERK pathway during cerebral ischemia in the rat","volume":"10","author":"A Maddahi","year":"2009","journal-title":"BMC Neurosci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0215398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:24:54Z","timestamp":1589009094000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0215398"}},"subtitle":[],"editor":[{"given":"Mateusz K.","family":"Holda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0215398","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]}}}